Semaglutide Goes Mainstream: Dr Reddy’s Lines Up Twin Launch In India And Canada

Nikunj Parikh May 12, 2026 310 Views

Dr Reddy’s Laboratories is set to launch semaglutide tablets in India within days, marking a major step in diabetes and obesity care. The company is also preparing a near-term rollout in Canada, signaling its growing global footprint in high-demand GLP-1 therapies.